Cargando…
RETRACTED: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
BACKGROUND: Hydroxychloroquine or chloroquine, often in combination with a second-generation macrolide, are being widely used for treatment of COVID-19, despite no conclusive evidence of their benefit. Although generally safe when used for approved indications such as autoimmune disease or malaria,...
Autores principales: | Mehra, Mandeep R, Desai, Sapan S, Ruschitzka, Frank, Patel, Amit N |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7255293/ https://www.ncbi.nlm.nih.gov/pubmed/32450107 http://dx.doi.org/10.1016/S0140-6736(20)31180-6 |
Ejemplares similares
-
Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
por: Mehra, Mandeep R, et al.
Publicado: (2020) -
Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis
por: The Lancet Editors
Publicado: (2020) -
Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.
por: Mehra, Mandeep R., et al.
Publicado: (2020) -
RETRACTED: Chloroquine or hydroxychloroquine for
COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020) -
Pharmacology of Chloroquine and Hydroxychloroquine
por: Browning, David J.
Publicado: (2014)